Ondřej Fiala, Petr Hošek, Michaela Tkadlecová, Bohuslav Melichar, Anežka Zemánková, Jindřich Kopecký, Michal Vočka, Martin Matějů, Radka Lohynská, Dominika Šiková, Petr Stránský, Hana Študentová, Martina Spisarová, Hana Nováková, Peter Priester, Dominika Kryštofová, Lucie Grmelová, Tomáš Büchler, Alexandr Poprach
{"title":"联合使用质子泵抑制剂或心血管药物对纳武单抗治疗转移性肾细胞癌患者生存结局的影响","authors":"Ondřej Fiala, Petr Hošek, Michaela Tkadlecová, Bohuslav Melichar, Anežka Zemánková, Jindřich Kopecký, Michal Vočka, Martin Matějů, Radka Lohynská, Dominika Šiková, Petr Stránský, Hana Študentová, Martina Spisarová, Hana Nováková, Peter Priester, Dominika Kryštofová, Lucie Grmelová, Tomáš Büchler, Alexandr Poprach","doi":"10.1007/s10585-025-10347-0","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10267,"journal":{"name":"Clinical & Experimental Metastasis","volume":"42 5","pages":"43"},"PeriodicalIF":3.2000,"publicationDate":"2025-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12317872/pdf/","citationCount":"0","resultStr":"{\"title\":\"Impact of concomitant use of proton pump inhibitors or cardiovascular medication on survival outcomes of patients with metastatic renal cell carcinoma treated with nivolumab.\",\"authors\":\"Ondřej Fiala, Petr Hošek, Michaela Tkadlecová, Bohuslav Melichar, Anežka Zemánková, Jindřich Kopecký, Michal Vočka, Martin Matějů, Radka Lohynská, Dominika Šiková, Petr Stránský, Hana Študentová, Martina Spisarová, Hana Nováková, Peter Priester, Dominika Kryštofová, Lucie Grmelová, Tomáš Büchler, Alexandr Poprach\",\"doi\":\"10.1007/s10585-025-10347-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10267,\"journal\":{\"name\":\"Clinical & Experimental Metastasis\",\"volume\":\"42 5\",\"pages\":\"43\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2025-08-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12317872/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical & Experimental Metastasis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10585-025-10347-0\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Experimental Metastasis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10585-025-10347-0","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
Impact of concomitant use of proton pump inhibitors or cardiovascular medication on survival outcomes of patients with metastatic renal cell carcinoma treated with nivolumab.
期刊介绍:
The Journal''s scope encompasses all aspects of metastasis research, whether laboratory-based, experimental or clinical and therapeutic. It covers such areas as molecular biology, pharmacology, tumor biology, and clinical cancer treatment (with all its subdivisions of surgery, chemotherapy and radio-therapy as well as pathology and epidemiology) insofar as these disciplines are concerned with the Journal''s core subject of metastasis formation, prevention and treatment.